Biotech China 2014

Drug Design: Harvard University

Total Score People Score Events Score
155 128 46
Date Event Presentation Speakers
February 6, 2011 5th Drug Discovery for Neurodegeneration: An Intensive Course for Translating Research into Drugs Academic Models of Drug Discovery Services & Utilizing CROs Marcie Glicksman
October 13, 2010 Making the Right Investments in Biomedical Informatics for Drug Development and Healthcare Meaningful Use and HIT Architectures for Health Care Innovation and Transformation Kenneth D Mandl
Transformational capability of biomedicalinformatics to change the way we do clinical R&D and deliver health care. Richard Platt
THEME B - Policy of Biomedical Informatics in Health Care and Pharma: FDAAA: Sentinel Initiative Richard Platt
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Opening Remarks Rakesh K Jain
Tumor Microenvironment I: Angiogenesis and Vascular Transport Rakesh K Jain
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: from Bench to Bedside to Biomarkers Rakesh K Jain
Tumor Microenvironment II: Interstitial and Lymphatic Transport Rakesh K Jain
Tumor Stroma Generation: Role of VPF/VEGF Harold F. Dvorak
Mining the Human Proteome: Biomarker Discovery for Human Cancer and Its Metastases Marsha Moses
Genetics in Cancer Therapy Raju Kucherlapati
Imaging Angiogenesis and Vascular Function in Cancer Patients A. Gregory Sorensen
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference Proteomic and informatic approaches in the study of the Ubiquitin Pathway Wade Harper
Keynote Address Alfred L. Goldberg
Inhibition of proteasomal deubiquitinating enzyme Usp14 Daniel Finley
Targeting Protein Degradatation as a Therapeutic Strategy in Myeloma Kenneth C Anderson
July 11, 2010 Translational Cancer Medicine 2010 (USA) Drugging “undruggable” transcriptional targets Gregory L Verdine
Novel strategies for drug development in oncology D. Gary Gilliland
Comprehensive genomic approaches to identify cancer targets William C Hahn
Modeling drug sensitivity and resistance in human tumor-derived cell lines Jeffrey Settleman
Functionalizing the cancer genome Lynda Chin
Title to be announced Levi A Garraway
Altered nutrient requirements in cells with activated mTOR complex 1 John Blenis
Title to be announced Shyamala Maheswaran
Title to be announced George Daniel Demetri
July 11, 2010 3rd International Congress On Stem Cells And Tissue Formation Biomaterials for Cell Transplantation and Drug Delivery | Amy Brock Amy Brock
Programming Cells In Vivo Using Polymers David J. Mooney
June 23, 2010 Structure-Based Drug Design In Silico Discovery of Small Molecule Transcription Factor Inhibitors Alan C Rigby
Chairperson’s Remarks Alan C Rigby
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
PANEL DISCUSSION Lynda Chin
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Healthcare Reform: Implications for the Industrial Sectors Yuan-Li Liu
February 1, 2010 4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE Session Overview Marcie Glicksman
II. In-vitro Testing: Early Phases of Drug Discovery Marcie Glicksman
Stem Cells to Accelerate Drug Discovery for Neurodegenerative Disease Lee Rubin
Developing Relevant High-Throughput Assays for the Identification of Potential Drug Candidates Marcie Glicksman
Track 1: Target Validation to Lead Optimization AD Case Study Marcie Glicksman
January 22, 2010 2010 Gastrointestinal Cancers Symposium General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: Prevention, Screening, and Diagnosis Sapna Syngal
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy Rakesh K Jain
Newer Radiation Techniques in the Treatment of Hepatobiliary and Pancreatic Cancers Harvey J. Mamon
Advanced Imaging Techniques Dushyant Sahani
Gastroenterologist William R. Brugge
Advanced Imaging Techniques Dushyant Sahani
November 2, 2009 Track 3: Fourth Annual Ion Channels as Therapeutic Targets Structural Insights into the Function of TRPV Channels Rachelle Gaudet
Ion Channel Drug Targets David E. Clapham
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells Genome-Subtractive Cancer-Specific Blood Assay Amin L Kassis
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine The Use of Genetically Engineered Mice for Preclinical Testing of Novel Cancer Therapeutics Kwok-Kin Wong
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery The chemical biology of behavior and psychiatric disease Randall Peterson
Drugging the "undruggable" Gregory Verdine
August 5, 2009 New Frontiers in Cancer Drug Development A New Paradigm for Translational Cancer Research: Targeting Endocrine Factors and Real Human Tumors Sandra S. McAllister
Turning Cancer Sequencing Data into Therapeutic Targets Heidi Greulich
Combinations of Novel and Conventional Cancer Agents: Challenges and Opportunities Kenneth C Anderson
The Use of Genetically Engineered Mouse Lung Cancer Models to Assess Effectiveness of Targeted Therapeutic Combinations Kwok-Kin Wong
The Evolving Treatment Paradigm in Multiple Myeloma Kenneth C Anderson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Michael Foley, Ph.D. Build-Couple-Pair Strategy for Diversity-Oriented Synthesis Yields a Unique Compound Collection for Probe Development and Drug Discovery Michael Foley
In Vivo Chemical Screening in Zebrafish Joanna Yeh
June 8, 2009 RNAi for Functional Screens Talk Title to Be Announced Caroline Shamu
April 22, 2009 PI 3-Kinase Signaling in Disease (Z3) PI 3-Kinase Signaling and Cancer Jeffrey Adam Engelman, Pier Paolo
February 24, 2009 11th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials Instituting Policies to Expedite Medicare Approval for Clinical Trial Costs and Expenses Douglass Reichgott
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Keynote Lectures Gregory L Verdine
Session 4: Chemistry in Support of Lead Discovery/Chemoinformatics Alan C Rigby
January 26, 2009 7th Annual Partnering with Central Labs Track A : Central Lab Cost Drivers and Logistics Discussion Forum David Mooney
January 5, 2009 High Content Analysis Multi-Color Live Cell Immunofluorescence Timecourse Analysis of Human-Induced Pluripotent Stem Cell Formation Thorsten M Schlaeger
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 12, 2008 Third Annual Post-Approval Drug Safety Strategies: Best Practices to Mitigate Risks throughout the Product's Life Cycle Establishing Best Practices in Evaluating, Planning and Executing “Fit-for-Purpose” Benefit/Risk Management Programs for the 21st Century Bjorn Olsen
November 3, 2008 ASAP-CHI Bio-Pharma Alliance Summit High Performing Collaborative Research Teams: Lessons from the Harvard Stem Cell Institute Brock Reeve
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Resolvins and Protectins : Anti-inflammatory and Pro-resolving Actions of Omega-3 Fatty Acid-derived Mediators Matthew Spite
August 19, 2008 Enabling Point-of-Care Diagnostics Leveraging Cell Phone Technology to Make Point-of-Care Diagnostics Accessible in the Developing World Boris Nikolic
August 11, 2008 CELLutions SUMMIT Programming Cells in Situ David Mooney
Developing Stem Cell-Based Therapies for Cancer Khalid Shah
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 2: Proteomics [sponsored by Merck Research Laboratories] Claude Lechene
Concurrent Morning Symposia 12: Systems Biology Josh LaBaer
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Proof of Concept to Pre-Clinical Scientist George Daniel Demetri
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
May 18, 2008 MAGI’s 2008 Clinical Trial Agreements, Budgets & Regulatory Conference – EAST Track B: Budgets Medicare Reimbursement for Clinical Trials Douglass Reichgott
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application (E2) GPCRs in Physiology 2 Jean-Pierre Vilardaga
April 28, 2008 Clinical Development of Therapeutic Antibodies Normalizing Tumor Vessels and Microenvironment to Treat Cancer: From the Bench to Bedside and Back Rakesh K Jain
March 30, 2008 Metabolic Pathways of Longevity Longevity and Insulin/IGF-I Signaling in Rodents C. Ronald Kahn
The Role of Nutrient Sensing in Aging II: Caloric Restriction David A Sinclair, Pere Puigserver
Oxidative Stress, Aging, & Insulin/IGF1 Signaling Evan Rosen
Mitochondria Dysfunction, Aging, & Insulin/IGF1 Vamsi K Mootha
March 30, 2008 Nuclear Receptors: Steroid Sisters Steroid Receptors and Chromatin Myles Brown
Analyses of Nuclear Receptor-Dependent Transcription (Joint) Myles Brown
Workshop 3 - Hot Topics: Chromatin/Transcription Mathieu Lupien
Steroid Receptor Biology Inna I. Astapova
Mechanisms of Receptor Action Pere Puigserver
Nuclear Receptor Biology (Joint) Bruce Spiegelman
March 30, 2008 Nuclear Receptors: Orphan Brothers Steroid Receptors and Chromatin Myles Brown
Analyses of Nuclear Receptor-Dependent Transcription (Joint) Myles Brown
Workshop 3 - Hot Topics: Chromatin/Transcription Mathieu Lupien
Mechanisms of Receptor Action Pere Puigserver
Steroid Receptor Biology Inna I. Astapova
Nuclear Receptor Biology (Joint) Bruce Spiegelman
March 25, 2008 2008 BIOPHARMA OUTSOURCING Identifying the Right CRO and Shepherding a Product in Preclinical Judith K Gwathmey
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Irene Bosch
Session 11: Identification of Novel and Effective Antiviral Treatment and zstablishment of Disease Pathogenesis: A journey of Global Gene Expression of dengue virus infection (11:20-11:40) Irene Bosch
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 2: Proteomics, Genomics and Biomarker Discovery Gregory L Verdine
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Rakesh K Jain
October 25, 2007 Pain Therapeutics Summit 2007 Workshop concludes / Conference registration begins David Borsook
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) TARGETING PAIN MANAGEMENT: TRP Channels as Drug Targets (14:30-15:00) David E. Clapham
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi as a Predictive Tool (14:20-15:25) Yaakov Benenson
RNAi as a Predictive Tool: RNAi-Based Molecular Logic Circuits (14:55-15:25) Yaakov Benenson
RNAi FOR IN VIVO TARGET VALIDATION (16:30-19:30) Anna Moore
RNAi FOR IN VIVO TARGET VALIDATION: In Vivo Imaging of siRNA Delivery and Silencing in Tumors (17:00-17:30) Anna Moore
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.